All Stories

  1. Towards evidence-based medicine for paediatricians
  2. Towards evidence-based medicine for paediatricians
  3. Measuring the ‘kindness’ of cancer treatment for children.
  4. Childhood, adolescent and young adult cancer and the prevalence of diagnosed autism or attention deficit hyperactivity disorder: A systematic review and meta-analysis
  5. Towards evidence-based medicine for paediatricians
  6. Why and When Are Evidence‐Based Interventions Adopted in Paediatric Supportive Care? A Qualitative Exploration of the Determinants of Photobiomodulation Implementation
  7. Towards evidence-based medicine for paediatricians
  8. Towards evidence-based medicine for paediatricians
  9. Towards evidence-based medicine for paediatricians
  10. Towards evidence-based medicine for paediatricians
  11. A systematic review and meta-analysis of the incidence of Pneumocystis jirovecii pneumonia (PJP) in children and young people with cancer, cancer-like conditions or haematopoietic stem cell transplants
  12. Towards evidence-based medicine for paediatricians
  13. Accuracy and Reliability of Remote Shoulder Motion Capturing Methods: A Systematic Review and Meta-Analysis
  14. A National Audit of Current UK Practice on the Use of Anti‐Emetics for Chemotherapy‐Induced Nausea and Vomiting in Children
  15. Priority setting for supportive care research in children and young people with cancer
  16. Towards evidence-based medicine for paediatricians
  17. Towards evidence-based medicine for paediatricians
  18. Do Surveillance Tests for Relapse Improve Survival After Chemotherapy for Paediatric Acute Leukaemia? A Systematic Review
  19. ‘All I Had to Do Was Open My Mouth Wide’—A Qualitative Exploration of the Acceptability of Photobiomodulation for Oral Mucositis Management in Paediatric Supportive Care
  20. Towards evidence-based medicine for paediatricians
  21. The Dangerousness of a Devilled Egg
  22. “That's All Anyone Needs Really, Support”: A Content Analysis of Retinoblastoma Survivors’ Psychosocial Support Needs
  23. Towards evidence-based medicine for paediatricians
  24. Towards evidence-based medicine for paediatricians
  25. Towards evidence-based medicine for paediatricians
  26. End of life care in paediatric settings: UK national survey
  27. Towards evidence-based medicine for paediatricians
  28. Towards evidence-based medicine for paediatricians
  29. Towards evidence-based medicine for paediatricians
  30. Towards evidence-based medicine for paediatricians
  31. Towards evidence-based medicine for paediatricians
  32. Towards evidence-based medicine for paediatricians
  33. Negotiating Neutrality: Designing a Responsive Video to Support Fertility Preservation Decision-making by Cancer-diagnosed Young Female Patients
  34. Towards evidence-based medicine for paediatricians
  35. Towards evidence-based medicine for paediatricians
  36. Consent and assent in paediatric practice: it’s the conversation that matters
  37. A systematic review of combined surgery and brachytherapy approaches for children and young people with relapsed and refractory rhabdomyosarcoma (Local‐REFoRMS)
  38. ‘It’s not meant to be for life, but it carries on’: a qualitative investigation into the psychosocial needs of young retinoblastoma survivors
  39. Towards evidence-based medicine for paediatricians
  40. Towards evidence-based medicine for paediatricians
  41. Towards evidence-based medicine for paediatricians
  42. Towards evidence-based medicine for paediatricians
  43. Lumps or granules?
  44. Towards evidence-based medicine for paediatricians
  45. Towards evidence-based medicine for paediatricians
  46. An analysis of the resource use and costs of febrile neutropenia events in pediatric cancer patients in Australia
  47. Towards evidence-based medicine for paediatricians
  48. Consultant-led UK paediatric palliative care services: professional configuration, services, funding
  49. Methods for including adult evidence in children's research.
  50. Towards evidence-based medicine for paediatricians
  51. Towards evidence-based medicine for paediatricians
  52. Comparison of Bayesian methods for incorporating adult clinical trial data to improve certainty of treatment effect estimates in children
  53. Towards evidence-based medicine for paediatricians
  54. Towards evidence-based medicine for paediatricians
  55. Using Evidence-Based Medicine to Support Clinical Decision-Making in RMS
  56. Can I go home now? The safety and efficacy of a new UK paediatric febrile neutropenia protocol for risk-stratified early discharge on oral antibiotics
  57. Towards evidence-based medicine for paediatricians
  58. An exploration of the use of photobiomodulation for management of oral mucositis in children and young people undergoing cancer treatment in the UK
  59. Towards evidence-based medicine for paediatricians
  60. Clostridioides difficile infection in paediatric patients with cancer and haematopoietic stem cell transplant recipients
  61. Towards evidence-based medicine for paediatricians
  62. Towards evidence-based medicine for paediatricians
  63. End of life care for infants, children and young people (ENHANCE): Protocol for a mixed methods evaluation of current practice in the United Kingdom
  64. Towards evidence-based medicine for paediatricians
  65. Towards evidence-based medicine for paediatricians
  66. PAnTher Cub: procalcitonin-guided antibiotic therapy for febrile neutropenia in children and young people with cancer - a single-arm pilot study
  67. Towards evidence-based medicine for paediatricians
  68. Prospective cohort study of the predictive value of inflammatory biomarkers over clinical variables in children and young people with cancer presenting with fever and neutropenia
  69. Towards evidence-based medicine for paediatricians
  70. Towards evidence-based medicine for paediatricians
  71. SARS-CoV-2 in children with cancer or after haematopoietic stem cell transplant: An analysis of 131 patients
  72. Towards evidence-based medicine for paediatricians
  73. Prospective cohort study of the predictive value of inflammatory biomarkers over clinical variables in children and young people with cancer presenting with fever and neutropenia
  74. Towards evidence-based medicine for paediatricians
  75. Towards evidence-based medicine for paediatricians
  76. Clinical practice guideline for the prevention of oral and oropharyngeal mucositis in pediatric cancer and hematopoietic stem cell transplant patients: 2021 update
  77. Towards evidence-based medicine for paediatricians
  78. COVID-19 in children with haematological malignancies
  79. Towards evidence-based medicine for paediatricians
  80. Reporting the whole story: Analysis of the ‘out‐of‐scope’ questions from the James Lind Alliance Teenage and Young Adult Cancer Priority Setting Partnership Survey
  81. Low-level laser therapy for oral mucositis in children with cancer
  82. External validation of clinical prediction models: simulation-based sample size calculations were more reliable than rules-of-thumb
  83. Mucositis reduction with probiotics in children with cancer: a randomised-controlled feasibility study
  84. Towards evidence-based medicine for paediatricians
  85. Procalcitonin and Interleukin-10 May Assist in Early Prediction of Bacteraemia in Children With Cancer and Febrile Neutropenia
  86. Towards evidence-based medicine for paediatricians
  87. Towards evidence-based medicine for paediatricians
  88. Towards evidence-based medicine for paediatricians
  89. Olanzapine was an effective additional antiemetic for children and young people undergoing highly emetogenic chemotherapy
  90. Prevention and treatment of anticipatory chemotherapy‐induced nausea and vomiting in pediatric cancer patients and hematopoietic stem cell recipients: Clinical practice guideline update
  91. UK paediatric oncology Pneumocystis jirovecii pneumonia surveillance study
  92. Towards evidence-based medicine for paediatricians
  93. Can low-dose dexamethasone be used instead of prednisolone in acute asthma attacks?
  94. Towards evidence-based medicine for paediatricians
  95. Towards evidence-based medicine for paediatricians
  96. Severity of COVID-19 in children with cancer: Report from the United Kingdom Paediatric Coronavirus Cancer Monitoring Project
  97. Improving symptom control and reducing toxicities for pediatric patients with hematological malignancies
  98. COVID‐19 and children with cancer: Parents’ experiences, anxieties and support needs
  99. Towards evidence-based medicine for paediatricians
  100. Towards evidence-based medicine for paediatricians
  101. Clinical Practice Guideline for Systemic Antifungal Prophylaxis in Pediatric Patients With Cancer and Hematopoietic Stem-Cell Transplantation Recipients
  102. Towards evidence-based medicine for paediatricians
  103. Conventional compared to network meta-analysis to evaluate antibiotic prophylaxis in patients with cancer and haematopoietic stem cell transplantation recipients
  104. Towards evidence-based medicine for paediatricians
  105. Home-based care of low-risk febrile neutropenia in children—an implementation study in a tertiary paediatric hospital
  106. Meta‐analytic validation of new ‘AUS’ febrile neutropenia risk score
  107. Towards evidence-based medicine for paediatricians
  108. Towards evidence-based medicine for paediatricians
  109. COVID-19 and children with cancer: Parents' experiences, anxieties, and support needs
  110. Prevalence of anticipatory nausea and vomiting in children undergoing cytotoxic chemotherapy for malignant disease - the SiCK2 (Sickness prior to Chemotherapy in Kids) study
  111. Re-evaluating and recalibrating predictors of bacterial infection in children with cancer and febrile neutropenia
  112. Children and young people’s concerns and needs relating to their use of health technology to self-manage long-term conditions: a scoping review
  113. A systematic review of evidence for and against routine surveillance imaging after completing treatment for childhood extracranial solid tumors
  114. Towards evidence-based medicine for paediatricians
  115. Sharing Roles and Control in Pediatric Low Risk Febrile Neutropenia: A Multicenter Focus Group Discussion Study Involving Patients, Parents, and Health Care Professionals
  116. Specialist paediatric palliative care for children and young people with cancer: A mixed-methods systematic review
  117. Towards evidence-based medicine for paediatricians
  118. Diagnostic Yield of Initial and Consecutive Blood Cultures in Children With Cancer and Febrile Neutropenia
  119. Towards evidence-based medicine for paediatricians
  120. Short-course antibiotics for chemotherapy-induced febrile neutropaenia: retrospective cohort study
  121. Baseline Chest Computed Tomography as Standard of Care in High-Risk Hematology Patients
  122. Towards evidence-based medicine for paediatricians
  123. Sensitivity of the Kaiser Permanente early-onset sepsis calculator: A systematic review and meta-analysis
  124. Lexicon for guidance terminology in pediatric hematology/oncology: A White Paper
  125. What’s not being said?
  126. Risk stratification in children with cancer and febrile neutropenia: A national, prospective, multicentre validation of nine clinical decision rules
  127. Towards evidence-based medicine for paediatricians
  128. Towards evidence-based medicine for paediatricians
  129. New developments in the prevention and management of infections in children with cancer
  130. Individual participant data validation of the PICNICC prediction model for febrile neutropenia
  131. Guideline for Antibacterial Prophylaxis Administration in Pediatric Cancer and Hematopoietic Stem Cell Transplantation
  132. Long duration of antibiotic therapy
  133. Towards evidence-based medicine for paediatricians
  134. Brincidofovir as a Salvage Therapy in Controlling Adenoviremia in Pediatric Recipients of Hematopoietic Stem Cell Transplant
  135. Neonates are not little children
  136. Interventions aiming to reduce time to antibiotics (TTA) in patients with fever and neutropenia during chemotherapy for cancer (FN), a systematic review
  137. Recommended technology to relieve oral mucositis not yet available for children or young people in England or Wales
  138. Towards evidence-based medicine for paediatricians
  139. Research priorities for young people with cancer: a UK priority setting partnership with the James Lind Alliance
  140. Towards evidence-based medicine for paediatricians
  141. Does routine surveillance imaging after completing treatment for childhood solid tumours cause more harm than good? A systematic review and meta-analysis protocol
  142. Association of time to antibiotics and clinical outcomes in patients with fever and neutropenia during chemotherapy for cancer: a systematic review
  143. How to navigate the ethical review of research
  144. Towards evidence-based medicine for paediatricians
  145. Framework to help design and review research involving children
  146. Towards evidence-based medicine for paediatricians
  147. How to involve children and young people in what is, after all, their research
  148. Towards evidence-based medicine for paediatricians
  149. Protocol for a systematic review of time to antibiotics (TTA) in patients with fever and neutropenia during chemotherapy for cancer (FN) and interventions aiming to reduce TTA
  150. Making research central to good paediatric practice
  151. Towards evidence-based medicine for paediatricians
  152. Fifteen-minute consultation: A guide to managing a child with a new finding of neutropenia
  153. Towards evidence-based medicine for paediatricians
  154. What do families want to improve in the management of paediatric febrile neutropenia during anti-cancer treatment? Report of a patient/public involvement group
  155. Refreshing
  156. Treating extravasation injuries in infants and young children: a scoping review and survey of UK NHS practice
  157. Towards evidence-based medicine for paediatricians
  158. Melatonin in children with cancer
  159. Towards evidence-based medicine for paediatricians
  160. The utility of routine surveillance screening with magnetic resonance imaging to detect tumor recurrence/progression in children with high‐grade central nervous system tumors: a systematic review
  161. Guideline for the Management of Clostridium Difficile Infection in Children and Adolescents With Cancer and Pediatric Hematopoietic Stem-Cell Transplantation Recipients
  162. Towards evidence-based medicine for paediatricians
  163. Towards evidence-based medicine for paediatricians
  164. Towards evidence-based medicine for paediatricians
  165. Treatment of extravasation injuries in infants and young children: a scoping review and survey
  166. Towards evidence-based medicine for paediatricians
  167. What is experimental?
  168. The utility of routine surveillance screening with magnetic resonance imaging (MRI) to detect tumour recurrence in children with low-grade central nervous system (CNS) tumours: a systematic review
  169. Quest for certainty regarding early discharge in paediatric low-risk febrile neutropenia: a multicentre qualitative focus group discussion study involving patients, parents and healthcare professionals in the UK
  170. Winter 2017 Children’s Cancer and Leukaemia Group febrile neutropenia audit
  171. Systematic review and meta-analysis investigating the efficacy and safety of probiotics in people with cancer
  172. Towards evidence-based medicine for paediatricians
  173. External Validation of Six Pediatric Fever and Neutropenia Clinical Decision Rules
  174. Towards evidence-based medicine for paediatricians
  175. ‘Inconguous’
  176. Je ne regrette rien?
  177. Towards evidence-based medicine for paediatricians
  178. Accuracy of cystatin C for the detection of abnormal renal function in children undergoing chemotherapy for malignancy: a systematic review using individual patient data
  179. Towards evidence based medicine for paediatricians
  180. “Let them eat strawberries”: Dietary restrictions for children with cancer
  181. Validation of a classification system for treatment-related mortality in children with cancer
  182. Bowing fracture of the inferior angle of the scapula, a difficult diagnosis
  183. Towards evidence-based medicine for paediatricians
  184. Towards evidence based medicine for paediatricians
  185. Survival rates and prognostic predictors of high grade brain stem gliomas in childhood: a systematic review and meta-analysis
  186. Predicting Infectious ComplicatioNs in Children with Cancer: an external validation study
  187. Risk Factors for Invasive Fungal Disease in Pediatric Cancer and Hematopoietic Stem Cell Transplantation: A Systematic Review
  188. Videolaryngoscopy versus direct laryngoscopy for tracheal intubation in children (excluding neonates)
  189. Towards evidence-based medicine for paediatricians
  190. Guideline for the prevention of acute chemotherapy-induced nausea and vomiting in pediatric cancer patients: A focused update
  191. Guidelines for the Prophylaxis of Pneumocystis jirovecii Pneumonia (PJP) in Children With Solid Tumors
  192. Towards evidence based medicine for paediatricians
  193. Observational study of the development and evaluation of a fertility preservation patient decision aid for teenage and adult women diagnosed with cancer: the Cancer, Fertility and Me research protocol
  194. Multi-Professional Perspectives on Adolescent and Young Adult Oncology Across Europe: An e-Delphi Survey
  195. Towards evidence based medicine for paediatricians
  196. Prospective cohort study of procalcitonin levels in children with cancer presenting with febrile neutropenia
  197. Towards evidence based medicine for paediatricians
  198. Clinical presentation of childhood leukaemia: a systematic review and meta-analysis
  199. Critical review of current clinical practice guidelines for antifungal therapy in paediatric haematology and oncology
  200. Risk stratification in febrile neutropenic episodes in adolescent/young adult patients with cancer
  201. The impact of routine surveillance screening with magnetic resonance imaging (MRI) to detect tumour recurrence in children with central nervous system (CNS) tumours: protocol for a systematic review and meta-analysis
  202. Galactomannan, β-D-Glucan, and Polymerase Chain Reaction–Based Assays for the Diagnosis of Invasive Fungal Disease in Pediatric Cancer and Hematopoietic Stem Cell Transplantation: A Systematic Review and Meta-Analysis
  203. Towards evidence based medicine for paediatricians
  204. Systematic review and meta‐analysis of the risk of severe and life‐threatening thromboembolism in cancer patients receiving anti‐EGFR monoclonal antibodies (cetuximab or panitumumab)
  205. The effectiveness and safety of proton beam radiation therapy in children with malignant central nervous system (CNS) tumours: protocol for a systematic review
  206. Towards evidence based medicine for paediatricians
  207. Strategies facilitating practice change in pediatric cancer: a systematic review
  208. Towards evidence based medicine for paediatricians
  209. Towards evidence based medicine for paediatricians
  210. Faculty of 1000 evaluation for Validation of two algorithms for managing children with a non-blanching rash.
  211. Guideline on children with challenging chemotherapy-induced nausea and vomiting
  212. Predicting microbiologically defined infection in febrile neutropenic episodes in children: global individual participant data multivariable meta-analysis
  213. Letter to the editor
  214. Towards evidence based medicine for paediatricians
  215. Variation in practice remains in the UK management of paediatric febrile neutropenia
  216. Antiemetic medication for prevention and treatment of chemotherapy-induced nausea and vomiting in childhood
  217. Aminoaciduria in the prediction of ifosfamide-induced tubulopathy after childhood cancer: a feasibility study
  218. Towards evidence based medicine for paediatricians
  219. QUESTION 1: Should we be using bisphosphonates for osteonecrosis complicating childhood acute lymphoblastic leukaemia?: Table 1
  220. Systematic review of reduced therapy regimens for children with low risk febrile neutropenia
  221. Towards evidence based medicine for paediatricians
  222. Classification of treatment-related mortality in children with cancer: a systematic assessment
  223. Management of fever and neutropenia in paediatric cancer patients
  224. The role of high-dose myeloablative chemotherapy with haematopoietic stem cell transplantation (HSCT) in children with central nervous system (CNS) tumours: protocol for a systematic review and meta-analysis
  225. Towards evidence based medicine for paediatricians
  226. Risk of grade 3-4 diarrhea and mucositis in colorectal cancer patients receiving anti-EGFR monoclonal antibodies regimens: A meta-analysis of 18 randomized controlled clinical trials
  227. Towards evidence based medicine for paediatricians
  228. Faculty of 1000 evaluation for Bronchiolitis of Infancy Discharge Study (BIDS): a multicentre, parallel-group, double-blind, randomised controlled, equivalence trial with economic evaluation.
  229. Towards evidence based medicine for paediatricians
  230. Nutritional support in children and young people with cancer undergoing chemotherapy
  231. Towards evidence based medicine for paediatricians
  232. Faculty of 1000 evaluation for Treatment of childhood anxiety disorder in the context of maternal anxiety disorder: a randomised controlled trial and economic analysis.
  233. Faculty of 1000 evaluation for Saline vs Tissue Plasminogen Activator Irrigations after Drain Placement for Appendicitis-Associated Abscess: A Prospective Randomized Trial.
  234. Towards evidence based medicine for paediatricians
  235. Faculty of 1000 evaluation for Large observer variation of clinical assessment of dyspnoeic wheezing children.
  236. Systematic Review and Meta-Analysis of Outcomes after Cardiopulmonary Arrest in Childhood
  237. Towards evidence based medicine for paediatricians
  238. Towards evidence based medicine for paediatricians
  239. Towards evidence based medicine for paediatricians
  240. Towards evidence based medicine for paediatricians
  241. PAWS for thought
  242. Faculty of 1000 evaluation for Pediatric patients who receive antibiotics for fever and neutropenia in less than 60 min have decreased intensive care needs.
  243. Bronchoalveolar Lavage and Lung Biopsy in Patients With Cancer and Hematopoietic Stem-Cell Transplantation Recipients: A Systematic Review and Meta-Analysis
  244. An emerging evidence base for PET-CT in the management of childhood rhabdomyosarcoma: systematic review
  245. Towards evidence based medicine for paediatricians
  246. Video-laryngoscopy versus direct laryngoscopy for tracheal intubation in children (excluding neonates)
  247. Critical Review of Clinical Practice Guidelines for Fertility Preservation in Teenagers and Young Adults with Cancer
  248. Core outcomes and definitions for pediatric fever and neutropenia research: A consensus statement from an international panel
  249. Towards evidence based medicine for paediatricians
  250. Question 2: Does the timing of central line placement in relationship to the initiation of acute lymphoblastic leukaemia therapy change the risk of thrombosis or infection?: Table 1
  251. Protocol for a systematic review of reductions in therapy for children with low-risk febrile neutropenia
  252. UK survey ofPneumocystis jiroveciiPneumonia (PJP) prophylaxis use in paediatric oncology patients: Table 1
  253. Mind the gap: extent of use of diffusion-weighted MRI in children with rhabdomyosarcoma
  254. Towards evidence based medicine for paediatricians
  255. A meta-analysis of cognitive impairment following adult cancer chemotherapy.
  256. Towards evidence based medicine for paediatricians
  257. Towards evidence based medicine for paediatricians
  258. Towards evidence based medicine for paediatricians
  259. Guideline for the prevention and treatment of anticipatory nausea and vomiting due to chemotherapy in pediatric cancer patients
  260. Towards evidence based medicine for paediatricians
  261. Leukapheresis and low-dose chemotherapy do not reduce early mortality in acute myeloid leukemia hyperleukocytosis: A systematic review and meta-analysis
  262. Faculty of 1000 evaluation for Hypotonic versus Isotonic Fluids in Hospitalized Children: A Systematic Review and Meta-Analysis.
  263. Towards evidence based medicine for paediatricians
  264. Faculty of 1000 evaluation for Topical Lidocaine to Improve Oral Intake in Children With Painful Infectious Mouth Ulcers: A Blinded, Randomized, Placebo-Controlled Trial.
  265. Towards evidence based medicine for paediatricians
  266. Increasing value and reducing waste in biomedical research regulation and management
  267. Towards evidence based medicine for paediatricians
  268. Towards evidence based medicine for paediatricians
  269. An Updated Systematic Review and Meta-analysis of the Predictive Value of Serum Biomarkers in the Assessment of Fever During Neutropenia in Children With Cancer
  270. Towards evidence based medicine for paediatricians
  271. Faculty of 1000 evaluation for Randomised, double-blind, placebo-controlled trial to determine whether steroids reduce the incidence and severity of nephropathy in Henoch-Schönlein purpura (HSP).
  272. Faculty of 1000 evaluation for Carriage of Mycoplasma pneumoniae in the upper respiratory tract of symptomatic and asymptomatic children: an observational study.
  273. Towards evidence based medicine for paediatricians
  274. The use of social-networking sites in medical education
  275. The reporting of outcomes in studies of fever and neutropenia in children with cancer: Time for consensus
  276. Towards evidence based medicine for paediatricians
  277. Question 2 * Can a conservative approach to the treatment of hypertrophic pyloric stenosis with atropine be considered a real alternative to surgical pyloromyotomy?
  278. Towards evidence based medicine for paediatricians
  279. A reaudit of current febrile neutropenia practice in UK paediatric oncology centres prior to implementation of NICE guidance
  280. Faculty of 1000 evaluation for Ultrasonographically guided peripheral intravenous cannulation of children and adults: A systematic review and meta-analysis.
  281. Faculty of 1000 evaluation for Cancer in children with nonchromosomal birth defects.
  282. The impact of a managed transition of care upon psychosocial characteristics and patient satisfaction in a cohort of adult survivors of childhood cancer
  283. Review: corticosteroids with intravenous immunoglobulin reduced the incidence of coronary artery aneurysm formation in patients with Kawasaki disease
  284. Faculty of 1000 evaluation for A new technique for fast and safe collection of urine in newborns.
  285. Developing a national ‘low risk’ febrile neutropenia framework for use in children and young people's cancer care
  286. Faculty of 1000 evaluation for Sexual activity-related outcomes after human papillomavirus vaccination of 11- to 12-year-olds.
  287. Towards evidence based medicine for paediatricians
  288. Faculty of 1000 evaluation for Antibiotic use in children and the use of medicines by parents.
  289. Towards evidence based medicine for paediatricians
  290. A systematic review of models of care for the follow‐up of childhood cancer survivors
  291. Rationalizing the approach to children with fever in neutropenia
  292. Updated Systematic Review and Meta-Analysis of the Performance of Risk Prediction Rules in Children and Young People with Febrile Neutropenia
  293. Fluoroquinolones in Children With Fever and Neutropenia
  294. Utility of peripheral blood cultures in patients with cancer and suspected blood stream infections: a systematic review
  295. Faculty of 1000 evaluation for Barriers to translating diagnostic research in febrile children to clinical practice: a systematic review.
  296. Predicting infectious complications in neutropenic children and young people with cancer (IPD protocol)
  297. Are we sure about the evidence for zinc in prophylaxis of the common cold?
  298. Systematic review and meta-analysis of the value of initial biomarkers in predicting adverse outcome in febrile neutropenic episodes in children and young people with cancer
  299. Towards evidence based medicine for paediatricians
  300. Faculty of 1000 evaluation for Scald risk in social housing can be reduced through thermostatic control system without increasing Legionella risk: a cluster randomised trial.
  301. Towards evidence based medicine for paediatricians
  302. Systematic review and meta‐analysis of the value of clinical features to exclude radiographic pneumonia in febrile neutropenic episodes in children and young people
  303. Faculty Opinions recommendation of Oral acyclovir suppression and neurodevelopment after neonatal herpes.
  304. Faculty of 1000 evaluation for Systematic review of studies comparing combined treatment with paracetamol and ibuprofen, with either drug alone.
  305. Towards evidence based medicine for paediatricians
  306. Faculty of 1000 evaluation for Randomised trial of sidecar crib use on breastfeeding duration (NECOT).
  307. A Home-based Maintenance Therapy Program for Acute Lymphoblastic Leukemia—Practical and Safe?
  308. Urine catecholamines in paediatrics
  309. Towards evidence based medicine for paediatricians
  310. Faculty of 1000 evaluation for Mental health problems among children one-year after Sichuan earthquake in China: a follow-up study.
  311. Faculty of 1000 evaluation for The stability of the diagnosis of developmental disability between ages 2 and 8 in a geographic cohort of very preterm children born in 1997.
  312. Towards evidence based medicine for paediatricians
  313. A simple practical patient-reported clinic satisfaction measure for young adults
  314. Systematic review and meta-analysis of the discriminatory performance of risk prediction rules in febrile neutropaenic episodes in children and young people
  315. Faculty of 1000 evaluation for Anti-emetic effect of ginger powder versus placebo as an add-on therapy in children and young adults receiving high emetogenic chemotherapy.
  316. Antiemetic medication for prevention and treatment of chemotherapy induced nausea and vomiting in childhood
  317. Supportive Care: Physical Consequences of Cancer and its Therapies
  318. Faculty of 1000 evaluation for Efficacy of sweet solutions for analgesia in infants between 1 and 12 months of age: a systematic review.
  319. ‘Cross hairs’ plots for diagnostic meta‐analysis
  320. Clinical decision rules: how to build them
  321. Clinical decision rules: how to use them
  322. Faculty of 1000 evaluation for Fusion gene-negative alveolar rhabdomyosarcoma is clinically and molecularly indistinguishable from embryonal rhabdomyosarcoma.
  323. Faculty of 1000 evaluation for Absolute and relative accuracy of rapid urine tests for urinary tract infection in children: a meta-analysis.
  324. Faculty of 1000 evaluation for Serum procalcitonin for prediction of renal parenchymal involvement in children with urinary tract infections: a meta-analysis of prospective clinical studies.
  325. Faculty Opinions recommendation of The likelihood of an indeterminate test result from a whole-blood interferon-gamma release assay for the diagnosis of Mycobacterium tuberculosis infection in children correlates with age and immune status.
  326. Challenges in the Management of Paediatric Febrile Neutropenia
  327. Faculty of 1000 evaluation for Influenza vaccination in children being treated with chemotherapy for cancer.
  328. Faculty of 1000 evaluation for Nebulized hypertonic saline solution for acute bronchiolitis in infants.
  329. F1000Prime recommendation of Evaluation of PICO as a knowledge representation for clinical questions.
  330. Faculty of 1000 evaluation for Does this child have acute otitis media?
  331. Systems for grading the quality of evidence and the strength of recommendations II: Pilot study of a new system
  332. Systems for grading the quality of evidence and the strength of recommendations I: Critical appraisal of existing approaches The GRADE Working Group